Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service
"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS
Ergebnis verändern
-
1
von Mark Slee ; Suzanne Hodgkinson ; Ernest Butler ; et al.
BMJ Neurology Open, Vol 3, Iss Suppl 1 (2021)
Schlagworte: Neurosciences. Biological psychiatry. Neuropsychiatry; RC321-571
-
2
von Müller, Jannis ; Sharmin, Sifat ; Lorscheider, Johannes ; et al.
JAMA neurology, Vol. 82, no.6, p. 614-625 (2025)
Schlagworte: Humans; Multiple Sclerosis; Relapsing-Remitting; Female; Male; Disease Progression; Adult; Retrospective Studies; Recurrence; Disability Evaluation; Middle Aged; Registries; Cohort Studies
-
3
von Toscano, Simona ; Spelman, Tim ; Ozakbas, Serkan ; et al.
Neurotherapeutics, Vol. 22, no.2, p. e00552 [1-12] (2025)
Schlagworte: Humans; Female; Multiple Sclerosis; Relapsing-Remitting; Male; Adult; Disease Progression; Treatment Outcome; Middle Aged; Follow-Up Studies; Prognosis; Registries; Magnetic Resonance Imaging; Time Factors; Disease-modifying treatment; High-efficacy drugs; Nomogram
-
4
von Siriratnam, Pakeeran ; Sanfilippo, Paul ; van der Walt, Anneke ; et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY ; ISSN: 0022-3050 ; ISSN: 1468-330X
Schlagworte: Medicine and Health Sciences; Biology and Life Sciences; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; IMMUNOLOGY; MEDICINE; HEALTH ECONOMICS; OPTICA SPECTRUM DISORDER; NEUROMYELITIS-OPTICA; DOUBLE-BLIND; EFFICACY; SAFETY; AZATHIOPRINE; SATRALIZUMAB; RITUXIMAB; OUTCOMES
-
5
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
-
6
von Sharmin, Sifat ; Roos, Izanne ; Malpas, Charles B ; et al.
The Lancet. Child & adolescent health, Vol. 8, no.5, p. 348-357 (2024)
Schlagworte: Adult; Child; Male; Humans; Female; Adolescent; Multiple Sclerosis; Relapsing-Remitting; Chronic Progressive; Fingolimod Hydrochloride; Registries
-
7
von Yeh, Wei Z ; Van Der Walt, Anneke ; Skibina, Olga G ; et al.
Neurology(R) neuroimmunology & neuroinflammation, Vol. 11, no.6, p. e200328 [1-16] (2024)
Schlagworte: Humans; Female; Pregnancy; Adult; Retrospective Studies; Antibodies; Monoclonal; Humanized; Immunologic Factors; Postpartum Period; Pregnancy Complications; Multiple Sclerosis; Relapsing-Remitting; Young Adult; Registries
-
8
von Yeh, Wei Z. ; Van Der Walt, Anneke ; Ozakbas, Serkan ; et al.
Schlagworte: multiple sclerosis (MS); Ocrelizumab (OCR); disease-modifying therapies (DMTs); women
-
9
von Maria Trojano ; Guglielmo Lucchese ; Giusi Graziano ; et al.
PLoS ONE, Vol 7, Iss 10, p e48078 (2012)
Schlagworte: Medicine; Science
-
10
von Spelman, Tim ; Eichau, Sara ; Alroughani, Raed ; et al.
MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL TRANSLATIONAL AND CLINICAL ; ISSN: 2055-2173
Schlagworte: Medicine and Health Sciences; Dimethyl fumarate; non-specific immunosuppressants; relapsing-remitting multiple sclerosis; real-world; effectiveness; REMITTING MULTIPLE-SCLEROSIS; PLACEBO-CONTROLLED PHASE-3; ORAL BG-12; AZATHIOPRINE; INDUCTION; THERAPIES; CANCER; RISK
- 11
-
12
von Wei Z. Yeh ; Anneke Van Der Walt ; Serkan Ozakbas ; et al.
Schlagworte: Neurosciences; multiple sclerosis (MS); Ocrelizumab (OCR); disease-modifying therapies (DMTs); women
-
13
von Tomas Kalincik ; Timothy Spelman ; Maria Trojano ; et al.
PLoS ONE, Vol 8, Iss 5, p e63480 (2013)
Schlagworte: Medicine; Science
-
14
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
von Foong, Yi Chao ; Merlo, Daniel ; Gresle, Melissa ; et al.
Schlagworte: Multiple sclerosis
-
15
von Kalincik, Tomas ; Sharmin, Sifat ; Roos, Izanne ; et al.
JAMA neurology, Vol. 80, no.7, p. 702-713 (2023)
Schlagworte: Female; Humans; Adult; Multiple Sclerosis; Natalizumab; Relapsing-Remitting; Fingolimod Hydrochloride; Hematopoietic Stem Cell Transplantation
-
16
von Spelman, Tim ; Ozakbas, Serkan ; Alroughani, Raed ; et al.
Neurodegenerative Disease Management, Vol. 13, no. 4, p. 215-221 (2023)
Schlagworte: cladribine tablets; dimethyl fumarate (Tecfidera®); fingolimod (Gilenya®); lay summary; multiple sclerosis; relapses; teriflunomide (Aubagio®); treatment options
-
17
von Zhu, Chao ; Kalincik, Tomas ; Horakova, Dana ; et al.
JAMA neurology, Vol. 80, no. 7, p. 739-748. (2023)
-
18
von Tim Spelman ; Serkan Ozakbas ; Aysun Soysal ; et al.
Schlagworte: Clinical sciences; Neurosciences; Applied and developmental psychology; cladribine tablets; dimethyl fumarate (Tecfidera); fingolimod (Gilenya); lay summary; multiple sclerosis; relapses
-
19
von Tim Spelman ; Melinda Magyari ; Helmut Butzkueven ; et al.
Frontiers in Neurology, Vol 14 (2023)
Schlagworte: multiple sclerosis; disease modifying treatment (DMT); treatment switching; disease registry; real world evidence (RWE); Neurology. Diseases of the nervous system; RC346-429
- 20
-
21
von Jodie I Roberts ; Sifat Sharmin ; Dana Horakova ; et al.
Schlagworte: CLINICAL NEUROLOGY; DEMYELINATING DISEASES; EVIDENCE-BASED NEUROLOGY; MULTIPLE SCLEROSIS
-
22
von Vitkova, Marianna ; Diouf, Ibrahima ; Malpas, Charles ; et al.
Neurology, Vol. 98, no. 24, p. e2401-e2412 (2022)
Schlagworte: Disability Evaluation; Female; Humans; Male; Multiple Sclerosis; Registries; Severity of Illness Index; Ultraviolet Rays
-
23
von Zhu, Chao ; Zhou, Zhen ; Roos, Izanne ; et al.
Journal of neurology, neurosurgery, and psychiatry, Vol. 93, no. 12, p. 1330-1337 (2022)
Schlagworte: Humans; Fingolimod Hydrochloride; Natalizumab; Cladribine; Multiple Sclerosis; Cohort Studies; Immunosuppressive Agents; Treatment Outcome; Relapsing-Remitting; Recurrence; Withholding Treatment; NEUROIMMUNOLOGY
-
24
von Kalincik, Tomas ; Kister, Ilya ; Bacon, Tamar E ; et al.
Multiple sclerosis, Vol. 28, no. 11, p. 1752-1761 (2022)
Schlagworte: Adult; Disability Evaluation; Disease Progression; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Prospective Studies; Recurrence; Severity of Illness Index; Multiple Sclerosis Severity Score (MSSS); prognostics; relapse prediction
-
25
von Montalban, Xavier ; Butzkueven, Helmut ; Spelman, Tim ; et al.
Schlagworte: Disease progression; Ocrelizumab; Primary progressive multiple sclerosis; Wheelchair
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag

Publikationstyp